342
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Interferon and Malignant Disease - How Does it Work and Why Doesn't it Always?

&
Pages 331-338 | Published online: 08 Jul 2009
 

Abstract

Since their first use at the clinic almost 30 years ago, interferons (IFNS) have become an accepted therapy in a range of malignancies. Although IFN will induce remissions in some patients, they are of no benefit, or at best, lead only to minor improvements in the great majority of patients. This review considers possible mechanisms underlying the antitumour effects of IFN, and discusses possible reasons for resistance to IFN therapy in patients with malignant disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.